POSTER SESSION II
Monday, March 3, 2008   —  1:00 PM - 4:30 PM
Convention Center, Exhibit Hall A


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




PULMONARY PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
208 The Etiology of Granulomatous Inflammation in Thoracic Biopsies: A Frequently Unresolved Diagnostic Problem (1559)
RC Guintu, NA Wylie, MA Morgan, AM Marchevsky - Cedars-Sinai Medical Center, Los Angeles, CA; Specialty Laboratories, Santa Clarita, CA
Add
209 Clinical and Pathologic Features of Non-Tuberculous Mycobacterial Respiratory Isolates (1544)
D Cohen, M Boos, G Hall, W Tomford, CF Farver - Cleveland Clinic, Cleveland, OH
Add
210 How Usual Is Usual Interstitial Pneumonia? Connective Tissue Disease-Associated Versus Idiopathic (1543)
NA Cipriani, JA Krishnan, I Noth, M Strek, T Krausz, AN Husain - University of Chicago, Chicago, IL
Add
211 Proliferative Activity in Fibrosing Lung Diseases: A Comparative Study of Ki-67 Immunoreactivity in Usual Interstitial Pneumonia, Bronchiolitis Obliterans-Organizing Pneumonia, and Diffuse Alveolar Damage (1555)
OA El-Zammar, A-LA Katzenstein - SUNY Upstate Medical University, Syracuse, NY
Add
212 Angiotensin II Antagonism Inhibits Collagen Deposition in Idiopathic Pulmonary Fibrosis (1591)
J Ramirez, A Xaubet, J Pereda, BD Uhal, X Li, M Molina-Molina - Hospital Clinic, CIBER. IDIBAPS, Enfermedades Respoiratorias; University of Barcelona, Barcelona, Spain; Michigan State University, East Lansing, MI
Add
213 Differences of Fibroblastic Foci of Usual Interstitial Pneumonia and Intraalveolar Buds of Chronic Organizing Pneumonia/Bronchiolitis Obliterans Organizing Pneumonia: Comparison of the Expression of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases (1581)
O Matsubara, N Imazeki, H Tsuda, Y Nakatani, EJ Mark - National Defense Medical College, Tokorozawa, Saitama, Japan; Chiba University, Chiba, Japan; Massachusetts General Hospital and Harvard Medical School, Boston, MA
Add
214 IL32 Is Overexpressed in Lung Tissue of Patients with COPD (1539)
F Calabrese, S Baraldo, E Bazzan, F Lunardi, P Sfriso, CA Dinarello, R Zuin, M Saetta - University of Padua, Padua, Italy; University of Colorado, Colorado
Add
215 Pulmonary Pathology Following Bone Marrow Transplantation (1573)
AR Laury, JS Truell, CK Lai, MC Fishbein - Brigham and Women's Hospital, Boston, MA; David Geffen School of Medicine at UCLA, Los Angeles, CA
Add
216 Clinicopathological Review of 50 Patients Receiving Hematopoietic Stem Cell Transplantation: Pulmonary Graft-Versus-Host Disease and Its Histological Mimics (1533)
MG Bayerl, WU Todd, RD Bruggeman, DS Zander - Penn State COM / MS Hershey Medical Center, Hershey, PA
Add
217 The Presence of a CD21+ Follicular Dendritic Cell Network Is Useful in Distinguishing Bronchus Associated Lymphoid Tissue from Pulmonary Acute Cellular Rejection (1596)
HA Sattar, T Krausz, S Bhorade, AN Husain - University of Chicago, Chicago, IL
Add
218 Idiopathic Tracheal Stenosis: A Clinicopathological Study of 63 Cases and Comparison of the Pathology to Chondromalacia (1582)
F Meng, EJ Mark, O Matsubara - Massachusetts General Hospital, Boston, MA
Add
219 Incidence and Significance of Benign Diagnoses on Core Needle Biopsies of Lung (1552)
EE Doxtader, S Mukhopadhyay, A-LA Katzenstein - SUNY Upstate Medical University, Syracuse, NY
Add
220 Pulmonary Meningothelial-Like Nodules: New Insights into a Common but Poorly Understood Entity (1587)
S Mukhopadhyay, OA El-Zammar, A-LA Katzenstein - State University of New York Upstate Medical University, Syracuse, NY
Add
221 Pulmonary Inflammatory Pseudotumor, Lymphoplasmacytic Sclerosing Variant: A Distinct Pulmonary Manifestation of IgG4-Related Systemic Fibrosclerosing Disease (1610)
Y Yonemori, T Fujii, Y Inayama, T Kishimoto, K Kameyama, K Hara, O Matsubara, T Tanizawa, K Hiroshima, Y Nakatani Chiba University, Chiba, Japan; Toranomon - Hospital, Tokyo, Japan; Yokohama City University, Yokohama, Japan; Keio University, Tokyo, Japan; Aichi Medical University, Aichi, Japan; National Defense Medical College, Tokorozawa, Japan
Add
222 Granulomatous Pleuritis: A Series of 57 Cases (1528)
R Albadine, N Le Stang, E Bergot, B Malbruny, A Jehan, JP Le Rochais, F Galateau-Salle - University Hospital; Mesonat Register; ERI3 INSERM and Mesopath Group, Caen, France
Add
223 The Accuracy of Pretreatment Biopsy of Pleural Malignant Mesothelioma in Predicting Histopathologic Type in Extrapleural Pneumonectomy (1556)
WC Foo, MD Hofer, DJ Sugarbaker, JM Corson, LR Chirieac - Brigham and Women's Hospital, Boston, MA
Add
224 Osteopontin, p-GSK-3b, b-Catenin, NF-kB, and HIF-1 Expression in 60 Diffuse Malignant Mesothelioma Cases: Correlation with Asbestos Exposure and Patient Demographics (1529)
TC Allen, PT Cagle, L Garza, M Pacienca, V Rouleau, F Morlais, G Launoy, F Galateau-Salle - Univ. of Texas Health Center-Tyler, Tyler, TX; The Methodist Hospital, Houston, TX; CHU, Caen, France
Add
225 Immunohistochemical Analysis of KOC/IMP3 in Malignant Pleural Mesothelioma (1609)
H Xu, R Simon, PA Bourne, BO Spaulding, HL Wang - University of Rochester Medical Center, Rochester, NY; Dako North America, Carpinteria, CA; Cedars-Sinai Medical Center, Los Angeles, CA
Add
226 Value of Immunohistochemical Markers in Differentiating Benign from Malignant Mesothelial Lesions (1527)
A Acurio, Q Arif, P Gattuso, M McIntere, T Krausz, AN Husain - Univ. of Chicago, Chicago, IL; Rush Univ, Chicago, IL
Add
227 Osteopontin and HIF-1 Expression in Diffuse Malignant Mesothelioma with Long-Term (>3 Year) Survival Versus Short-Term Survival (1530)
TC Allen, HH Popper, H Kothmaier, I Halbwedl, P Morbini, B Murer, CE Comin, F Galateau-Salle, F Demirag, H Zeren, R Attanoos, A Gibbs, PT Cagle - University of Texas Health Center-Tyler, Tyler, TX; Institute of Pathology, Graz, Austria; Instituto di Anatomia Patologica, Pavia, Italy; Ospedale Umberto, Mestre-Venezia, Italy; University of Firenze, Firenze, Italy; CHU Cote de Nacre, Caen, France; Ataturk Chest Disease Hospital, Ankara, Turkey; Adana University, Adana, Turkey; Llandough Hospital, Cardiff, United Kingdom; The Methodist Hospital, Houston, TX
Add
228 Prognostic Significance of p16/CDKN2A Deletion in Pleural Mesotheliomas (1547)
S Dacic, HH Popper, H Kothmaier, I Halbwedl, P Morbini, B Murer, CE Comin, F Galateau-Salle, F Demirag, H Zeren, R Attanoos, A Gibbs, PT Cagle - University of Pittsburgh, Pittsburgh; Institute of Pathology, Graz, Austria; Instituto di Anatomia Pathologica, Pavia, Italy; Ospedale Umberto, Mestre-Venezia, Italy; University of Firenze, Firenze, Italy; CHU Cote de Nacre, Caen, France; Ataturk Chest Disease Hospital, Ankara, Turkey; Adana University, Adana, Turkey; Cardiff and Vale NHS Trust Llandough Hospital, Cardiff, United Kingdom; The Methodist Hospital, Houston
Add
229 Immunohistochemical Expression of c-Met Receptor Tyrosine Kinase (c-Met) Has Prognostic Significance and Its Activation Is Related to Phosphorylated Protein Kinase C b (p-PKC b) in Malignant Mesothelioma (MM) (1608)
M Westerhoff, L Faoro, S Loganathan, R Salgia, T Krausz, AN Husain - University of Chicago, Chicago, IL
Add
230 Expression of Matrix Metalloproteinase-7 in 45 Diffuse Malignant Mesotheliomas: Potential Target for Therapy (1558)
JM Gardner, TC Allen, J Jagirdar, HH Popper, PT Cagle - Weill College of Medicine Cornell University, The Methodist Hospital, Houston, TX; University of Texas Health Center, Tyler, TX; University of Texas Health Science Center, San Antonio, TX; Medical University of Graz, Graz, Austria
Add
231 Expression of Alpha-Methylacyl-COA Racemase in Tissue Microarray of 39 Cases of Diffuse Malignant Mesothelioma (1550)
DW Davis, QJ Zhai, W Li, D Tan, TC Allen, HH Popper, PT Cagle - University of Texas Health Science Center, Houston, TX; The Methodist Hospital/Weill Cornell Medical School, Houston, TX; University of Texas M.D.Anderson Cancer Center, Houston, TX; University of Texas Health Center, Tyler, TX; Institute of Pathology, Medical University of Graz, Graz, Austria
Add
232 D2-40, Mesothelin, Podoplanin and Other Mesothelioma-Related Markers in Thymic Tumors: A Tissue Microarray Analysis of 57 Cases (1569)
T Khoury, A Arshad, M Arnouk, D Tan - Roswell Park Cancer Institute, Buffalo, NY; MD Anderson, Houston, TX
Add
233 Gene Expression Profiling of Pulmonary Neuroendocrine Tumors: Identifying Clinically Useful Tumor Markers for Diagnosis and Treatment (1592)
MS Roh, WD Travis, WL Gerald - Dong-A University College of Medicine, Busan, Korea; Memorial Sloan-Kettering Cancer Center, New York, NY
Add
234 Loss of Expression of von Hipple-Lindau Gene Product in Moderately and Poorly Differentiated Neuroendocrine Carcinoma of the Lung - A Possible Role in Carcinogenesis (1598)
J Shi, H Liu, W Jin, F Lin - Geisinger Medical Center, Danville, PA; Fujian Medical University, Fuzhou, Fijian, China
Add
235 Bcl-2 Expression in Pulmonary Neuroendocrine Neoplasms: A Tissue Microarray Study (1540)
MD Chiselite, NM Deal, IJ Check, SM Share, TC Pereira, JS Coon, TA Hensing, RK Orr, KW Lannert, MJ Liptay, JA Howington, CD Sturgis - Evanston Northwestern Healthcare, Evanston; Rush University, Chicago; Allegheny General Hospital, Pittsburgh
Add
236 Lack of E-Cadherin and Pan-Cadherin Immunoexpression Is Associated with Metastasis in Small Cell Lung Cancer (1561)
AK Haque, N Singhal, T Allen, R Barrios, A Sienko, PT Cagle - The Methodist Hospital, Houston, TX; University of Texas Tyler, Tyler, TX
Add
237 Expression of HIF-1 Alpha in Pulmonary Non-Small Cell Carcinomas and Neuroendocrine Carcinomas - A Tissue Microarray Analysis of 442 Cases (1534)
MB Beasley, CY Castro, L Garza, TC Allen, PT Cagle - Mt. Sinai Med Ctr, New York, NY; Holmes Reg Med Ctr, Melbourne, FL; The Methodist Hospital, Houston, TX; Univ of Texas Health Ctr, Tyler, TX
Add
238 c-Met Expression in Pulmonary Neuroendocrine Tumors (1603)
J Song, MS Tretiakova, R Salgia, PT Cagle, AN Husain - Univ of Chicago, Chicago, IL; The Methodist Hospital, Houston, TX
Add